EPS8L2 Gene
EPS8 Like 2: A regulator of actin dynamics and receptor signaling
Gene Information Card
| Symbol | EPS8L2 |
|---|---|
| Full Name | EPS8 like 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 11p15.5 |
| NCBI Gene ID | 64787 ncbi.nlm.nih.gov/gene/64787 |
| Ensembl ID | ENSG00000134824 |
| UniProt ID | Q9H6S3 |
| OMIM ID | 614827 |
| HGNC ID | 21247 |
| Aliases | EPS8R2, FLJ21908 |
Description
EPS8L2 (EPS8 like 2) is a protein-coding gene that belongs to the EPS8 family of signaling adaptors. The encoded protein contains an N-terminal phosphotyrosine-binding (PTB) domain, a central SH3 domain, and a C-terminal sterile alpha motif (SAM) domain. It functions as a regulator of actin cytoskeleton dynamics by modulating the activity of the actin-capping protein complex and participates in receptor tyrosine kinase signaling, particularly downstream of EGFR. EPS8L2 is involved in cell migration, proliferation, and endocytosis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hearing loss, autosomal recessive 102 | Loss-of-function mutations in EPS8L2 disrupt stereocilia actin regulation in inner ear hair cells, leading to sensorineural hearing loss. | ClinVar, OMIM |
| Colorectal cancer | Altered EPS8L2 expression may contribute to aberrant EGFR signaling and cytoskeletal remodeling in tumor progression. | COSMIC, NCBI Gene |
| Breast cancer | EPS8L2 overexpression has been observed in some breast cancer cell lines, potentially affecting cell motility. | COSMIC |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | Medium |
| Heart | 8.3 | Low |
| Kidney | 15.2 | Medium |
| Liver | 6.1 | Low |
| Lung | 10.4 | Medium |
| Testis | 20.7 | High |
| Thyroid | 14.8 | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 18.5 | Embryonic kidney cells; moderate expression |
| HeLa | 22.3 | Cervical cancer cells; high expression |
| MCF7 | 16.1 | Breast cancer cells; moderate expression |
| A549 | 12.9 | Lung cancer cells; moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1?) | missense | Rare | Likely loss of start codon; predicted to abolish protein expression |
| c.325C>T (p.Arg109*) | nonsense | Rare | Premature stop; loss of function associated with hearing loss |
| c.1045G>A (p.Gly349Arg) | missense | Rare | Uncertain significance; may affect SAM domain function |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift variants that truncate the protein or disrupt key domains (e.g., p.Arg109*) are classified as loss-of-function.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in EPS8L2.
Dominant Negative (DN)
No dominant-negative mutations described for EPS8L2.
View complete mutation data:
Gene Ontology (GO)
| • actin filament capping | • actin cytoskeleton organization |
| • signal transduction | • epidermal growth factor receptor signaling pathway |
| • protein binding | • SH3 domain binding |
Pathways
• EGFR signaling pathway (Reactome: R-HSA-177929)
• Actin nucleation by ARP-WASP complex (Reactome: R-HSA-5663213)
• Regulation of actin dynamics for phagocytic cup formation (Reactome: R-HSA-2029481)
Protein Summary
The EPS8L2 protein (UniProt Q9H6S3) is a 715-amino-acid adaptor molecule that localizes to the cytoplasm and cell cortex. It contains a PTB domain (residues 1-120), an SH3 domain (residues 200-260), and a SAM domain (residues 600-660). Through its SH3 domain, it interacts with EPS8 and ABI1 to form a complex that regulates actin capping. The PTB domain mediates binding to phosphotyrosine residues on activated receptors such as EGFR. EPS8L2 is essential for normal hearing, as it maintains the precise actin architecture of stereocilia in inner ear hair cells.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| EPS8L2 Knockout HEK293 Cell Line | EDJ-KQ13309 | Human | 64787 | Details Get a Quote |
| EPS8L2 Knockout A-549 Cell Line | EDJ-KQ42764 | Human | 64787 | Details Get a Quote |
| EPS8L2 Knockout HCT 116 Cell Line | EDJ-KQ42765 | Human | 64787 | Details Get a Quote |
| EPS8L2 Knockout HeLa Cell Line | EDJ-KQ42766 | Human | 64787 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records